Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Screen, Systematic Evaluation and Risk Warning of Polyvascular Disease Based on Multi-modality Imaging

NCT06016608 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT06016608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06016608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Screen, Systematic Evaluation and Risk Warning of Polyvascular Disease Based on Multi-modality Imaging
Lead sponsor
Harbin Medical University
Phase
Observational
Overall status
Recruiting
Start date
October 18, 2023
Completion date
December 31, 2025
Enrollment
1,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polyvascular disease